Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Actuate Therapeutics, Inc. (ACTU) had Normalized Income after Taxes of $-5.95M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-5.95M |
|
-- |
|
-- |
|
$5.97M |
|
$-5.97M |
|
$0.02M |
|
$-5.95M |
|
$-5.95M |
|
$-5.95M |
|
$-5.95M |
|
$-5.95M |
|
|
Normalized Income after Taxes |
$-5.95M |
$-5.97M |
|
$-5.97M |
|
19.65M |
|
19.65M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$6.69M |
|
-- |
|
$0.28M |
|
$6.97M |
|
$9.20M |
|
-- |
|
$0.42M |
|
$9.62M |
|
$-2.65M |
|
$-2.65M |
|
$-2.65M |
|
20.47M |
|
| Cash Flow Statement Financials | |
$-8.79M |
|
-- |
|
$6.64M |
|
$8.64M |
|
$6.49M |
|
$-2.15M |
|
$2.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.79M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
224.19% |
|
224.19% |
|
-85.37% |
|
224.19% |
|
$-0.13 |
|
$-0.45 |
|
$-0.45 |
|